Gainers
- PLx Pharma PLXP stock increased by 7.5% to $10.17 during Tuesday's after-market session. The company's market cap stands at $280.0 million.
- Cellectar Biosciences CLRB shares increased by 4.99% to $0.73. The company's market cap stands at $44.6 million.
- Celyad Oncology CYAD stock rose 4.76% to $4.62. The market value of their outstanding shares is at $74.3 million.
- Cardiff Oncology CRDF stock moved upwards by 3.62% to $5.71. The market value of their outstanding shares is at $239.6 million.
- OncoSec Medical ONCS stock increased by 3.59% to $1.44. The market value of their outstanding shares is at $56.4 million.
- BioSig Technologies BSGM stock rose 3.35% to $2.77. The market value of their outstanding shares is at $97.8 million.
Losers
- Ensysce Biosciences ENSC stock declined by 5.65% to $3.01 during Tuesday's after-market session. This security traded at a volume of 2.9 million shares come close, making up 336.01% of its average volume over the last 100 days. The market value of their outstanding shares is at $73.0 million.
- NeoGenomics NEO shares decreased by 5.22% to $32.16. This security traded at a volume of 104.5K shares come close, making up 10.42% of its average volume over the last 100 days. The company's market cap stands at $3.9 billion.
- Evoke Pharma EVOK stock decreased by 4.02% to $0.56. The market value of their outstanding shares is at $18.3 million.
- Ekso Bionics Holdings EKSO stock declined by 3.94% to $3.17. The company's market cap stands at $40.1 million.
- Beyond Air XAIR stock fell 3.05% to $10.51. The market value of their outstanding shares is at $279.9 million.
- SINTX Technologies SINT shares declined by 2.98% to $0.76. The market value of their outstanding shares is at $18.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in